Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-27, Stock:ABBV, The news for the past five days is as follows:
2021-05-20: NEWS1: AbbVie to Present at the UBS Global Healthcare Virtual Conference.NEWS2: 5 Biopharma Stocks That Are Cheap and Growing.
2021-05-21: NEWS1: Jim Simons' Firm's Top Trades of the 1st Quarter.NEWS2: 10 Best American Dividend Stocks to Invest In.NEWS3: 2 Healthcare Stocks Perfect to Buy Now and Hold Until Retirement.
2021-05-24: NEWS1: Big Drug Stocks Have Rallied. Why an Analyst Says They Have More Room to Run..NEWS2: 10 Best Dividend Stocks to Buy According to Billionaire Mario Gabelli.NEWS3: AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI®)  Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Crohn's Disease.NEWS4: The Lancet Publishes Results from Pivotal Global Phase 3 Program Evaluating RINVOQ® (upadacitinib) in Atopic Dermatitis.NEWS5: JNJ's Stelara Fails to Beat AbbVie's Humira In Crohn's Disease Patients.
2021-05-25: NEWS1: AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheumatology.NEWS2: AbbVie Receives European Commission Approval of VENCLYXTO® (venetoclax) in Combination with a Hypomethylating Agent for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy.NEWS3: 2 High-Yield Dividend Stocks for 2021.NEWS4: 3 Strong Stocks for Your Income Tax Return.
2021-05-26: NEWS1: AbbVie: The Market Can't See Beyond Humira.NEWS2: AbbVie's (ABBV) Venclyxto Gets EU Nod for First-Line AML.NEWS3: AbbVie to Present at Bernstein's 37th Annual Strategic Decisions Conference.NEWS4: AbbVie to Present Data from its Leading Migraine Portfolio at the 2021 American Headache Society (AHS) Annual Scientific Meeting.NEWS5: 5 Reasons Not to Sell During a Market Crash.

Answer: Decrease